268 related articles for article (PubMed ID: 22182574)
1. An in vitro comparative assessment with a series of new triphenyltin(IV) 2-/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with anticancer activities: structural modifications, analysis of efficacy and cytotoxicity involving human tumor cell lines.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2012 Feb; 107(1):119-28. PubMed ID: 22182574
[TBL] [Abstract][Full Text] [Related]
2. Molecular basis of the interaction of novel tributyltin(IV) 2/4-[(E)-2-(aryl)-1-diazenyl]benzoates endowed with an improved cytotoxic profile: synthesis, structure, biological efficacy and QSAR studies.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Pellerito C; Singh P; Verma P; Duthie A; de Vos D; Verma RP; Englert U
J Inorg Biochem; 2010 Sep; 104(9):950-66. PubMed ID: 20553814
[TBL] [Abstract][Full Text] [Related]
3. Advancement towards tin-based anticancer chemotherapeutics: structural modification and computer modeling approach to drug-enzyme interactions.
Basu Baul TS; Dutta D; de Vos D; Höpfl H; Pooja ; Singh P
Curr Top Med Chem; 2012; 12(24):2810-26. PubMed ID: 23368104
[TBL] [Abstract][Full Text] [Related]
4. Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Singh P; Verma P; de Vos D
Invest New Drugs; 2010 Oct; 28(5):587-99. PubMed ID: 19641849
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, crystal structures, cytotoxicity and qualitative structure-activity relationship (QSAR) of cis-bis{5-[(E)-2-(aryl)-1-diazenyl]quinolinolato}di-n-butyltin(IV) complexes, (n)Bu2Sn(L)2.
Basu Baul TS; Mizar A; Chandra AK; Song X; Eng G; Jirásko R; Holcapek M; de Vos D; Linden A
J Inorg Biochem; 2008 Sep; 102(9):1719-30. PubMed ID: 18571240
[TBL] [Abstract][Full Text] [Related]
6. Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies.
Baul TS; Basu S; de Vos D; Linden A
Invest New Drugs; 2009 Oct; 27(5):419-31. PubMed ID: 18941713
[TBL] [Abstract][Full Text] [Related]
7. Triphenyltin(IV) benzoates with diazenyl/imino scaffold exhibiting remarkable apoptosis mediated by reactive oxygen species.
Basu Baul TS; Dutta D; Duthie A; Prasad R; Rana NK; Koch B; Tiekink ERT
J Inorg Biochem; 2017 Aug; 173():79-92. PubMed ID: 28505480
[TBL] [Abstract][Full Text] [Related]
8. Dibutyltin(IV) complexes containing arylazobenzoate ligands: chemistry, in vitro cytotoxic effects on human tumor cell lines and mode of interaction with some enzymes.
Basu Baul TS; Paul A; Pellerito L; Scopelliti M; Singh P; Verma P; Duthie A; de Vos D; Tiekink ER
Invest New Drugs; 2011 Apr; 29(2):285-99. PubMed ID: 20012338
[TBL] [Abstract][Full Text] [Related]
9. Diorganotin(IV) complexes of dipeptides containing the alpha-aminoisobutyryl residue (Aib): preparation, structural characterization, antibacterial and antiproliferative activities of [(n-Bu)2 Sn(H(-1)L)] (LH=H-Aib-L-Leu-OH, H-Aib-L-Ala-OH).
Katsoulakou E; Tiliakos M; Papaefstathiou G; Terzis A; Raptopoulou C; Geromichalos G; Papazisis K; Papi R; Pantazaki A; Kyriakidis D; Cordopatis P; Manessi-Zoupa E
J Inorg Biochem; 2008 Jul; 102(7):1397-405. PubMed ID: 18289688
[TBL] [Abstract][Full Text] [Related]
10. Syntheses, molecular structures, electrochemical behavior, theoretical study, and antitumor activities of organotin(IV) complexes containing 1-(4-chlorophenyl)-1-cyclopentanecarboxylato ligands.
Shang X; Meng X; Alegria EC; Li Q; Guedes da Silva MF; Kuznetsov ML; Pombeiro AJ
Inorg Chem; 2011 Sep; 50(17):8158-67. PubMed ID: 21793560
[TBL] [Abstract][Full Text] [Related]
11. The triphenyltin(VI) complexes of NSAIDs and derivatives. Synthesis, crystal structure and antiproliferative activity. Potent anticancer agents.
Dokorou V; Primikiri A; Kovala-Demertzi D
J Inorg Biochem; 2011 Feb; 105(2):195-201. PubMed ID: 21194618
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, structural characterization and in vitro cytotoxicity and anti-bacterial activity of some copper(I) complexes with N,N'-disubstituted thioureas.
Rauf MK; Imtiaz-ud-Din ; Badshah A; Gielen M; Ebihara M; Vos Dd; Ahmed S
J Inorg Biochem; 2009 Aug; 103(8):1135-44. PubMed ID: 19570580
[TBL] [Abstract][Full Text] [Related]
13. Diorganotin(IV) derivatives of substituted benzohydroxamic acids with high antitumor activity.
Li Q; da Silva MF; Pombeiro AJ
Chemistry; 2004 Mar; 10(6):1456-62. PubMed ID: 15034889
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, photophysical properties and structures of organotin-Schiff bases utilizing aromatic amino acid from the chiral pool and evaluation of the biological perspective of a triphenyltin compound.
Basu Baul TS; Kehie P; Duthie A; Guchhait N; Raviprakash N; Mokhamatam RB; Manna SK; Armata N; Scopelliti M; Wang R; Englert U
J Inorg Biochem; 2017 Mar; 168():76-89. PubMed ID: 28024187
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, structural characterization and in vitro inhibitory studies against human breast cancer of the bis-(2,6-di-tert-butylphenol)tin(IV) dichloride and its complexes.
Shpakovsky DB; Banti CN; Beaulieu-Houle G; Kourkoumelis N; Manoli M; Manos MJ; Tasiopoulos AJ; Hadjikakou SK; Milaeva ER; Charalabopoulos K; Bakas T; Butler IS; Hadjiliadis N
Dalton Trans; 2012 Dec; 41(48):14568-82. PubMed ID: 23052471
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation inhibition and antitumor activity of novel alkyl series of diorganotin(IV) compounds.
Koch B; Baul TS; Chatterjee A
J Appl Toxicol; 2008 May; 28(4):430-8. PubMed ID: 17668440
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, characterization, antimicrobial and antitumor screening of some diorganotin(IV) complexes of 2-[(9H-Purin-6-ylimino)]-phenol.
Rehman W; Badshah A; Khan S; Tuyet le TA
Eur J Med Chem; 2009 Oct; 44(10):3981-5. PubMed ID: 19464768
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, structural characterization and in vitro biological screening of some homoleptic copper(II) complexes with substituted guanidines.
Murtaza G; Rauf MK; Badshah A; Ebihara M; Said M; Gielen M; de Vos D; Dilshad E; Mirza B
Eur J Med Chem; 2012 Feb; 48():26-35. PubMed ID: 22177420
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, structural characterization and in vitro cytotoxicity of diorganotin (IV) diimido complexes.
Yin H; Yue C; Hong M; Cui J; Wu Q; Zhang X
Eur J Med Chem; 2012 Dec; 58():533-42. PubMed ID: 23164659
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and characterization of fluorescent pyrrolyldipyrrinato Sn(IV) complexes.
Crawford SM; Al-Sheikh Ali A; Cameron TS; Thompson A
Inorg Chem; 2011 Sep; 50(17):8207-13. PubMed ID: 21786802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
